Archived Seminar: Sex, Drugs and Radiomics of Brain Cancer
Pioneers in Biomedical Research Seminar presented by the Fralin Biomedical Research Institute at VTC
Archived Seminar: Sex, Drugs and Radiomics of Brain Cancer
Date: Dec. 4, 2020
Time: 11:00 a.m. - 12:00 p.m.
About this Seminar
Glioblastoma are notoriously aggressive, malignant primary brain tumors that have variable response to treatment. This presentation will focus on the integrative role of 1) biological sex-differences, 2) heterogeneity in drug-delivery and 3) intra-tumoral molecular diversity (revealed by radiomics) in capturing and predicting this variable response to treatment. Specifically, Dr. Swanson will highlight burgeoning insights into sex differences in tumor incidence, outcomes, propensity and response to therapy. She will further quantify the degree to which heterogeneity in drug delivery, even for drugs that are able to bypass the blood-brain barrier, contributes to differences in treatment response. Lastly, she will propose an integrative role for spatially resolved MRI-based radiomics models to reveal the intra-tumoral biological heterogeneity that can be used to guide treatment targeting and management.
Additional Details
This is a free event hosted by the Fralin Biomedical Research Institute and co-sponsored by the institute's Cancer Research Group. The Fralin Biomedical Research Institute Pioneers in Biomedical Research Program offers the expertise of a range of scientists who are exploring frontiers in biomedical research. These seminars are open to Virginia Tech and Carilion Clinic faculty, students, and staff.
You May Also Be Interested In...
-
Home Item
Seminar: Precision Medicine of Biological Drugs for Brain Cancer , homeDec. 7, 2023, 11 a.m. | Professor, Department of Diagnostic Radiology and Nuclear Medicine, University of Maryland School of Medicine | Seminar | Children's National Research and Innovation Campus
-
Home Item
In Person at CNRIC: Hyperactivation of an RNA Binding Protein by Cancer-associated Mutations , homeDec. 8, 2023, 11:00 a.m., Collaboratory, Children's National Research and Innovation Campus, Washington, D.C. | Daniel Dominguez, Ph.D., Assistant Professor, Pharmacology, UNC School of Medicine | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Group
-
Home Item
In Person Seminar: An Epigenome Atlas of the Embryonic Mouse Brain to Study Interneuron Neurogenesis in Normal Development and Disease Models , homeDec. 15, 2023, 11:00 a.m. | Timothy Petros, Ph.D., Investigator, Unit on Cellular and Molecular Neurodevelopment, Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health | Co-Sponsored by the Fralin Biomedical Research Institute Center for Neurobiology Research
-
Home Item
In Person Seminar: Quantitative Proteomics for Understanding Epigenetic Cancer Mechanisms , homeJan. 12, 2024, 11 a.m. | Ben Garcia, Ph.D., Raymond H. Wittcoff Distinguished Professor and Head, Department of Biochemistry and Molecular Biophysics, Washington University School of Medicine | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Cancer Research Group
-
Home Item
In Person Seminar: Building and Maintaining Biological Tubes , homeJan. 19, 2024, 11 a.m. | Ondine Cleaver, Ph.D., Professor, Molecular Biology, University of Texas Southwestern Medical Center | Pioneers in Biomedical Research Seminar Series | Co-Sponsored by the Fralin Biomedical Research Institute Center for Vascular and Heart Research
Kristin R. Swanson, Ph.D.
The Vasek and Anna Maria Polak Professor in Cancer Research; Professor of Neurological Surgery, Molecular Neuroscience, and Radiation Oncology; Mayo Clinic, Phoenix, Arizona